Vertex Pharmaceuticals VRTX Income Statements

Conto economico

Quarter End	Dic 2022	Mar 2023	Giu 2023	Set 2023	Dic 2023	Mar 2024	Giu 2024	Set 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	2,3B	2,37B	2,5B	2,48B	2,57B	2,69B	2,65B	2,77B
Reddito operativo	1,03B	777,1M	1,03B	1,04B	988,5M	1,14B	-3,51B	1,12B
Reddito ante imposte	1,08B	891,5M	1,16B	1,18B	1,1B	1,28B	-3,39B	1,22B
Reddito netto	818,9M	699,8M	915,7M	1,04B	919,6M	1,1B	-3,59B	1,05B
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	0	0	0	0	0	0	0	0
UTILE OPERATIVO	994,5M	778,4M	1,03B	1,02B	963,1M	1,11B	-3,51B	1,1B
EBITDA	1,07B	815,9M	1,07B	1,08B	1,05B	1,19B	-3,46B	1,17B

Fine anno 31 Dicembre 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	1,7B	2,49B	3,05B	4,16B	6,21B	7,58B	8,99B	9,92B
Reddito operativo	9,94M	123,24M	635,15M	1,2B	2,86B	2,78B	4,31B	3,83B
Reddito ante imposte	-67,37M	-15,69M	600,24M	1,39B	3,12B	2,73B	4,23B	4,33B
Reddito netto	-112,05M	263,48M	2,1B	1,18B	2,71B	2,34B	3,32B	3,57B
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	-0.451	1.04	8.218	4.544	10.434	9.204	12.925	13.856
UTILE OPERATIVO	9,94M	41,86M	634,36M	1,26B	2,98B	2,79B	4,32B	3,79B
EBITDA	71,33M	441,93M	736,57M	1,3B	2,97B	2,91B	4,46B	4,01B